1. 1424PThe plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial). (23rd October 2018) Authors: Usui, K; Yokoyama, T; Kisohara, A; Mori, Y; Takeda, Y; Ishida, H; Kusano, N; Kishi, K; Katsushima, U; Kuwako, T; Aono, H; Shikama, Y; Minato, K; Matsushima, H; Uemura, K; Ohashi, Y; Kunitoh, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 48PEstrogen-related receptor α as a potential molecular target for endometrial cancer therapy. (23rd October 2018) Authors: Kokabu, T; Mori, T; Matsushima, H; Tarumi, Y; Yoriki, K; Kuroboshi, H; Sawada, M; Umemura, S; Kitawaki, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗